Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walid Shalata

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Anti-Cancer Drugs|January 20, 2021
Is alectinib-induced elevation of creatine phosphokinase a predictive factor for response? Report of two cases and review of the literatureWalid Shalata, Ismaell Massalha, Abed Agbarya
Cancers|August 27, 2021
Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and FutureWalid Shalata, Binil Mathew Jacob, Abed Agbarya
Journal of Clinical Medicine|December 10, 2021
Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and FutureChun Ho Szeto, Walid Shalata, Alexander Yakobson, et al.
Journal of Thoracic Disease|September 13, 2024
Long-term effect of corticosteroid treatment during acute COVID-19 infection on pulmonary function test resultsLiora Boehm Cohen, Yael Raviv, Walid Shalata, et al.
Journal of Glaucoma|September 6, 2023
Assessment of the iCare HOME2, a New Intraocular Pressure Self-Measurement TonometerAssaf Kratz, Rabia Zbidat, Rina Kishner, et al.
Anti-Cancer Drugs|July 7, 2021
Pulmonary toxicity following administration of granulocyte colony-stimulating factor during chemotherapy for breast cancer: a case report and literature reviewWalid Shalata, Lauren Waichenberg, Ismaell Massalha, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 18, 2021
Encephalitis Induced by Durvalumab During Treatment of Metastatic Small-Cell Lung Cancer: Illustrative Case and Review of the LiteratureYelena Shechtman, Walid Shalata, Rasha Khoury, et al.
Cancers|August 26, 2023
PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell CarcinomaAlexander Yakobson, Ashraf Abu Jama, Omar Abu Saleh, et al.
Case Reports in Oncology|June 11, 2020
Associated Myocarditis: A Predictive Factor for Response?Walid Shalata, Nir Peled, Itzhak Gabizon, et al.
Clinics and Practice|September 22, 2023
Bullous Pemphigoid Occurring after Stopping Imatinib Therapy of CML: Is a Continuation of Post-Treatment Follow-Up Needed?Alexander Yakobson, Ala Eddin Neime, Omar Abu Saleh, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Anti-Cancer Drugs|January 20, 2021
Is alectinib-induced elevation of creatine phosphokinase a predictive factor for response? Report of two cases and review of the literatureWalid Shalata, Ismaell Massalha, Abed Agbarya
Cancers|August 27, 2021
Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and FutureWalid Shalata, Binil Mathew Jacob, Abed Agbarya
Journal of Clinical Medicine|December 10, 2021
Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and FutureChun Ho Szeto, Walid Shalata, Alexander Yakobson, et al.
Journal of Thoracic Disease|September 13, 2024
Long-term effect of corticosteroid treatment during acute COVID-19 infection on pulmonary function test resultsLiora Boehm Cohen, Yael Raviv, Walid Shalata, et al.
Journal of Glaucoma|September 6, 2023
Assessment of the iCare HOME2, a New Intraocular Pressure Self-Measurement TonometerAssaf Kratz, Rabia Zbidat, Rina Kishner, et al.
Anti-Cancer Drugs|July 7, 2021
Pulmonary toxicity following administration of granulocyte colony-stimulating factor during chemotherapy for breast cancer: a case report and literature reviewWalid Shalata, Lauren Waichenberg, Ismaell Massalha, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 18, 2021
Encephalitis Induced by Durvalumab During Treatment of Metastatic Small-Cell Lung Cancer: Illustrative Case and Review of the LiteratureYelena Shechtman, Walid Shalata, Rasha Khoury, et al.
Cancers|August 26, 2023
PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell CarcinomaAlexander Yakobson, Ashraf Abu Jama, Omar Abu Saleh, et al.
Case Reports in Oncology|June 11, 2020
Associated Myocarditis: A Predictive Factor for Response?Walid Shalata, Nir Peled, Itzhak Gabizon, et al.
Clinics and Practice|September 22, 2023
Bullous Pemphigoid Occurring after Stopping Imatinib Therapy of CML: Is a Continuation of Post-Treatment Follow-Up Needed?Alexander Yakobson, Ala Eddin Neime, Omar Abu Saleh, et al.
Pageof 8